Scinai Immunotherapeutics Ltd Net Asset Quality Index
Scinai Immunotherapeutics Ltd net asset quality index. Scinai Immunotherapeutics Ltd (SCNI) has a Net Asset Quality Index of 68.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $17.17 Million minus total liabilities of $5.44 Million yields net assets of $11.73 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Scinai Immunotherapeutics Ltd for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Scinai Immunotherapeutics Ltd (2000–2025)
Net asset quality index of Scinai Immunotherapeutics Ltd from 2000 to 2025. This chart shows how Scinai Immunotherapeutics Ltd's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of June 2026, the index stands at 68.3%, representing net assets of $11.73 Million against total assets of $17.17 Million USD. Check SCNI strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Scinai Immunotherapeutics Ltd Net Asset Quality Index by Year (2000–2025)
Scinai Immunotherapeutics Ltd net asset quality index by year from 2000 to 2025. The table below presents the year-by-year Net Asset Quality Index for Scinai Immunotherapeutics Ltd from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see SCNI stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 69.7% | $8.10 Million | $11.63 Million | $3.52 Million | ▼ -4.5 pp |
| 2024 | 74.2% | $9.98 Million | $13.45 Million | $3.47 Million | ▲ +100.3 pp |
| 2023 | -26.2% | $-4.57 Million | $17.47 Million | $22.04 Million | ▼ -19.6 pp |
| 2022 | -6.5% | $-1.76 Million | $27.07 Million | $28.83 Million | ▼ -9.6 pp |
| 2021 | 3.1% | $982.00K | $32.04 Million | $31.05 Million | ▲ +28.7 pp |
| 2020 | -25.6% | $-4.54 Million | $17.71 Million | $22.25 Million | ▲ +30.6 pp |
| 2019 | -56.2% | $-18.84 Million | $33.52 Million | $52.36 Million | ▼ -26.7 pp |
| 2018 | -29.5% | $-8.35 Million | $28.30 Million | $36.65 Million | ▼ -98.3 pp |
| 2017 | 68.9% | $16.17 Million | $23.48 Million | $7.31 Million | ▼ -16.2 pp |
| 2016 | 85.1% | $6.65 Million | $7.82 Million | $1.17 Million | ▲ +3.9 pp |
| 2015 | 81.2% | $8.61 Million | $10.60 Million | $1.99 Million | ▼ -8.6 pp |
| 2014 | 89.8% | $4.26 Million | $4.74 Million | $481.23K | ▼ -3.0 pp |
| 2013 | 92.9% | $6.92 Million | $7.45 Million | $529.76K | ▼ -2.7 pp |
| 2012 | 95.6% | $5.95 Million | $6.22 Million | $272.58K | ▲ +1.9 pp |
| 2011 | 93.7% | $6.71 Million | $7.16 Million | $450.86K | ▲ +2.3 pp |
| 2010 | 91.5% | $7.94 Million | $8.68 Million | $742.07K | ▼ -2.8 pp |
| 2009 | 94.3% | $8.44 Million | $8.95 Million | $512.67K | ▲ +0.5 pp |
| 2008 | 93.8% | $3.00 Million | $3.20 Million | $197.78K | ▲ +653.8 pp |
| 2007 | -560.0% | $-3.31 Million | $592.00K | $3.91 Million | ▼ -647.9 pp |
| 2006 | 87.9% | $1.74 Million | $1.98 Million | $240.00K | ▲ +7.1 pp |
| 2005 | 80.8% | $2.70 Million | $3.35 Million | $643.00K | ▲ +1.1 pp |
| 2004 | 79.7% | $4.11 Million | $5.15 Million | $1.04 Million | ▲ +53.2 pp |
| 2003 | 26.5% | $648.00K | $2.44 Million | $1.80 Million | ▲ +21.2 pp |
| 2002 | 5.3% | $90.00K | $1.70 Million | $1.61 Million | ▲ +405.3 pp |
| 2001 | -400.0% | $-4.00K | $1.00K | $5.00K | ▲ +400.0 pp |
| 2000 | -800.0% | $-24.00K | $3.00K | $27.00K | — |